Physician profile
Aaron W Johnson
NPI 1083804041
$503.58
in general payments reported to CMS, 2019-2025
11 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.62 · 2022: $31.65 · 2023: $47.07 · 2024: $99.53 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $279.55 | 2024-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $50.58 | 2025 | |
| Grifols USA, LLC | $34.54 | 2023-2025 | Prolastin-C Liquid |
| Janssen Pharmaceuticals, INC | $31.65 | 2022 | |
| Pfizer INC. | $18.76 | 2025 | |
| Viatris Specialty LLC | $18.52 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.29 | 2025 | Jardiance |
| Boston Scientific Corporation | $14.57 | 2023 | Bodyguardian |
| Shield Therapeutics INC | $14.41 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.09 | 2023 | Xifaxan |
| Indivior INC. | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.